Recent Headlines
Within Pharmaceuticals
DN Designs Launches Culture-Driven Branding Program to Support India’s Bharat-First Startup Wave
DN Designs launches a new Regional Culture-Driven Branding Program dedicated to helping Indian startups infuse regional languages, motifs, folklore, typography, and cultural storytelling into their brand identities and packaging — tailored for Bharat-first audiences. - December 01, 2025 - DN Designs
KMS Technology Unveils Refreshed Brand Identity to Reflect Its AI-First Evolution
KMS Technology, a strategic engineering company empowering businesses to turn bold ideas into high-impact solutions faster, today announced the launch of its refreshed brand identity. Featuring a new logo, color palette, and messaging, the rebrand signals the company’s transformation into an... - November 28, 2025 - KMS Technology
DDi Selected by a Large $2 Billion Medical Device Company to Streamline Regulatory Strategy, Intelligence and Assessments
DDi has been selected by a UK-based US $2B medical-device company to streamline its global regulatory strategy, intelligence operations, and regulatory assessments. The partnership strengthens compliance, accelerates market readiness, and leverages DDi’s advanced Visu regulatory-process platform. - November 24, 2025 - DDi LLC
Elabscience® Announces Antibody Technology Upgrade and Product Portfolio Enhancement
Elabscience® has announced a major upgrade to its antibody product portfolio with the adoption of recombinant rabbit monoclonal antibody technology. This innovation significantly enhances antibody specificity, reproducibility, and stability, meeting the growing global demand for high-performance research reagents. - November 19, 2025 - Elabscience
DelivHer Launches Anu™ by DelivHer: The First Disposable, Fluid-Retentive Menstrual Disc Designed Specifically for Heavy, Clot-Rich Flow
Anu™ by DelivHer stands apart from other menstrual discs and cups with its fluid-retentive Leak-Lock™ technology, locking in both fluid and clots for leak-free, extended wear and mess-free removal - finally providing real protection for women with heavier-than-normal cycles. - November 17, 2025 - Anu by DelivHer
Botanical Advocacy and Education (BAE) Launches to Promote Pure, Safe and Natural Solutions for Public Health
Botanical Advocacy and Education’s goal is to educate all people to the truth about botanicals. BAE is a Nonprofit that has been formed to reenergize Grassroots Advocacy and Education for the purpose of protecting the right of all American adults to use natural, unadulterated Botanicals for the purposes they choose. - November 17, 2025 - Botanical Advocacy and Education
Empact Health Consulting Launches to Redefine Healthcare Leadership with Compassion and Operational Excellence
Empact Health Consulting, a division of BFG Brown Financial Group, has launched to redefine healthcare leadership by combining strategic insight with compassion. The firm partners with hospitals, clinics, and healthcare organizations to strengthen culture, streamline operations, and enhance both employee well-being and patient outcomes. Founder Shawn T. Brown stated that Empact aims to “ensure compassion and efficiency coexist in every aspect of healthcare delivery. - November 13, 2025 - Empact Health Consulting
Parvus Therapeutics Reports Positive Phase 1 Results for Lead Autoimmune Treg Therapy, PVT201
PVT201 demonstrated favorable safety, predictable pharmacokinetics, and on-target pharmacodynamic activity in first-in-human study. - November 12, 2025 - Parvus Therapeutics U.S., Inc.
Healing the Invisible Wounds of War: Veterans Rebuild Lives After Combat
From the battlefield to civilian life, veterans reveal how understanding the mind helped them overcome post-service stress. - November 11, 2025 - Bridge Publications
Alera Bio Announces Appointment of Board of Directors
Alera Bio, a Chicago-based biotech developing therapies for rare neuroendocrine and neurological disorders, announced its inaugural Board of Directors. The board includes leaders in biopharma, clinical practice, and finance, such as Stephen Hill, Mark Prygocki, Renny Griffith, and Cassius Coleman. Their combined expertise will guide Alera Bio as it advances AB-101 for MCT-8 deficiency, an FDA-designated Rare Pediatric Disease therapy. - November 11, 2025 - Alera Bio
McObject Releases eXtremeDB/rt 2.0: Persistent Hard Real-Time Database System with Breakthrough Deadline and Flash Memory Control
McObject has released eXtremeDB/rt 2.0, the next evolution of its hard real-time database system. Now supporting persistent storage with deterministic flash management and advanced deadline scheduling, version 2.0 ensures predictable performance even under extreme workload and timing constraints. Ideal for aerospace, industrial, and safety-critical environments where timing precision truly matters. - November 04, 2025 - McObject
MVT Reports Breakthrough Preclinical Results for MVT‑101 in DVT Model
Microvascular Therapeutics, Inc. (MVT) today announced the publication of compelling preclinical data demonstrating that its proprietary phase‑shift microbubble platform, MVT‑101 (Solv), significantly enhances sonothrombolysis in a clinically relevant porcine model of deep vein thrombosis (DVT). The study appears in the peer‑reviewed journal Nanotheranostics (Vol. 9, Issue 3, 2025). - November 04, 2025 - Microvascular Therapeutics, Inc.
Ales for ALS Reaches 300+ Breweries in 2025 — Limited Spots Still Open to Join This Year
Ales for ALS™ announced today that more than 300 breweries across the United States and around the world have joined the 2025 program—poised to make this year one of the largest in the initiative’s 12-year history. Limited hop allocations remain available, and interested breweries are encouraged to enroll soon to secure one of the final shipments for the year. - October 31, 2025 - ALS Therapy Development Institute
True Marker Pharmaceuticals Hits Another Trust & Credibility Milestone
True Marker Pharmaceuticals, Inc., a licensed pharmaceutical wholesaler and repackager based in Phoenix, has earned BBB Accreditation, recognizing its commitment to ethical business practices, transparency, and regulatory compliance. The achievement aligns with True Marker’s expanding U.S. distribution network and reinforces its reputation as a trusted, DSCSA-compliant partner to independent pharmacies and healthcare providers nationwide. - October 28, 2025 - True Marker Pharmaceuticals, Inc.
Fleming Events Launches “Digital Quality in Clinical Trials” Training to Address New ICH E6 (R3) GCP Expectations
Fleming Events, a global provider of professional training and industry knowledge programs, has announced its upcoming masterclass Digital Quality in Clinical Trials, scheduled for 22–23 April 2026 in Vienna, Austria. The training comes at a critical time as regulators worldwide increase... - October 28, 2025 - Fleming Events
Liminatus Pharma, Inc. Signs MOU with Capital Trust Group for USD 30 Million Equity Investment via an earn-out mechanism and Future Strategic Cooperation
Liminatus Pharma, Inc. (NASDAQ: LIMN), La Palma, CA, a clinical-stage immuno-oncology company developing next-generation CD47-blockade therapies, announced today that it has entered into a Memorandum of Understanding (MOU) with Capital Trust Group Limited (CTG), a New Zealand-based investment... - October 27, 2025 - Liminatus Pharma, Inc
Finetech Updates All Plastic Ampoule Filling Machines; Now Introduces 1 New Series of Machines
Finetech has launched a new line of plastic ampoule filling machines designed to meet small-dose filling needs, suitable for filling solutions for test drugs, cosmetics, health products and food. - October 27, 2025 - Finetech
Precision Antibody to Present Expertise in High-Quality Biomarker Antibodies at the World ADC Conference 2025
Precision Antibody will showcase its biomarker antibody expertise at the World ADC Conference 2025 in San Diego, highlighting its role in advancing ADC and cancer biomarker research through high-quality monoclonal antibody development. - October 25, 2025 - Precision Antibody
New Study Shows Self-Guided Online Exercise Program Significantly Improves Strength and Reduces Fall Risk in Midlife and Older Women
A new study to be presented at The Menopause Society (TMS) 2025 Annual Meeting by Osteoboost Health shows that a self-guided, online exercise program led to rapid and clinically meaningful improvements in leg strength and endurance — key factors in reducing fall risk — in women ages 40... - October 21, 2025 - Osteoboost Health
Cancer Prevention Nanomedicine Platform Advances Toward Preclinical Development Phase
Elixira, a Swedish nanomedicine innovation designed to function as an artificial immune system for lifelong cancer prevention, is preparing for the preclinical development phase — marking a key milestone toward the world’s first preventive nanomedicine platform. The company has now... - October 19, 2025 - Elixira
New Report Uncovers What Sponsors Really Think About Preclinical Services and CROs
Life Science Strategy Group’s Preclinical Services Landscape and CRO Benchmarking Assessment Delivers Data-Driven Insights on Budgets, Outsourcing, Vendor Preferences, and Industry Shifts - October 16, 2025 - Life Science Strategy Group, LLC
Precision Antibody to Showcase High-Affinity, Epitope-Rich, and Fully Functional Antibody Capabilities at Antibody Engineering & Therapeutics Asia 2025
Precision Antibody will showcase its high-affinity, epitope-rich, and fully functional antibody development technologies at Antibody Engineering & Therapeutics Asia 2025 in Kyoto, highlighting innovations that accelerate discovery and therapeutic antibody programs worldwide. - October 15, 2025 - Precision Antibody
Hemanext Inc. Awarded $2.9M NIH Grant to Advance Clinical Initiatives in the United States
Hemanext Inc has been awarded a three-year Small Business Innovation Research Grant (SBIR) Phase II for a project titled, “Efficacy of Hypoxic Red Blood Cells Processed with the Hemanext ONE® System in Patients with Sickle Cell Anemia,” to support and strengthen the clinical efforts of hypoxically stored red blood cells (HRBC) in the United States. - October 14, 2025 - Hemanext
New GCP Training Aligned with ICH E6(R3) from Pharma Lessons
Pharma Lessons is pleased to announce the launch of its newly revised Good Clinical Practice (GCP) online training course, now fully aligned with the latest ICH GCP E6(R3) guidance. This update incorporates the key enhancements introduced by ICH E6(R3), including a stronger focus on risk-based... - October 14, 2025 - Pharma Lessons
Precision Antibody to Showcase Fully Human Monoclonal Antibody Development at the 19th Drug Discovery Strategic Summit in San Francisco
Precision Antibody will present its fully human monoclonal antibody development platform at the 19th Drug Discovery Strategic Summit, highlighting rapid, royalty-free antibody solutions advancing cancer research and drug discovery. - October 14, 2025 - Precision Antibody
Cellionyx Exits Stealth Mode with Cytomotion, an FDA-Registered Class I Electroceutical Device Set to Redefine Human Healing and Performance
Cellionyx today emerged from stealth to launch Cytomotion, a first-in-class, FDA-Registered Class I medical device. Shifting the paradigm to true cellular regeneration, Cytomotion utilizes precision-directed electrical fields to activate the body’s innate repair mechanisms. Validated through its licensee Equstech in the elite high performance equestrian sports market, the technology accelerates recovery from injury and proactively optimizes human performance. Commercial launch November 12, 2025. - October 13, 2025 - Cellionyx
IVC Hosts Charity Golf Tournament, Donates $100,000 to Support Local Communities
IVC proudly hosted its annual Charity Golf Tournament on October 8 at The Cliffs at Mountain Park Golf Club, bringing together employees, partners, and community members for a day of camaraderie, giving, and impact. As part of the event, IVC donated $50,000 each to March of Dimes in Anderson, SC,... - October 11, 2025 - International Vitamin Corporation
Radial Celebrates the Grand Opening of Its Second South Carolina Clinic in Downtown Conway
More than 60 community members and business leaders join for ribbon cutting ceremony with the Conway Chamber of Commerce. - October 11, 2025 - Radial
Abel Womack Launches Newly Redesigned Website
Enhancing Customer Experience Across Forklift, Automation, and Intralogistics Solutions - October 01, 2025 - Abel Womack Inc
Aquaterra Biotech Launches Integrated DNA-to-GMP CDMO Platform in Québec
Aquaterra Biotech Launches Integrated Microbial CDMO Platform from DNA Design to GMP Release Aquaterra Biotech announced an integrated contract development and manufacturing (CDMO) platform that advances microbial and recombinant programs from DNA design to GMP release and logistics. Headquartered... - September 30, 2025 - Aquaterra Biotech
The FOXG1 Research Foundation Announces FDA Award of Orphan Drug Designation for FRF-001 Gene Therapy, Following Rare Pediatric Disease Designation
The FOXG1 Research Foundation announced the FDA has granted Orphan Drug and Rare Pediatric Disease designations to FRF-001, its gene therapy for FOXG1 syndrome. FRF-001 marks a historic first: a parent-led foundation sponsoring its own international, multi-site clinical trial. - September 29, 2025 - FOXG1 Research Foundation
Alera Bio Announces Appointment of Executive Leadership Team
Alera Bio announced its executive team: Philip Vorhies (CEO), Peter Thomson (CFO), Eric Floyd, PhD (CRO), and Caitlin Murray (GC), supported by expert consultants. Founder Frank Jaeger noted their strength in biotech, finance, regulatory, and legal, positioning Alera to advance AB-101 for MCT-8 deficiency, a rare neurological disorder with FDA Rare Pediatric Disease designation. - September 26, 2025 - Alera Bio
Madison Avenue Group Announces Christine Nguyen as Official Partner
In 2021, Madison Avenue Group was founded with a clear mission: to help brands scale and grow through the power of influencer marketing. What began as a solo venture by founder Hollie Nguyen has now grown into a partnership built on strength, resilience, and vision. - September 26, 2025 - Madison Ave Group
New Chief Commercial Officer Joins Hemanext Team to Drive Execution
Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, is pleased to welcome Mr. Shane Ray to the team as Chief Commercial Officer (CCO). In this role, Shane will lead the global commercial strategy and execution for Hemanext ONE®. - September 24, 2025 - Hemanext
Natural Cure Labs’ Level Off Gains Traction as Americans Seek Metabolic Health
Natural Cure Labs has updated its Level Off glucose support supplement to include loquat leaf extract, expanding the formula’s evidence base for healthier post-meal glucose balance. With only 12% of U.S. adults metabolically healthy, the enhancement underscores rising demand for natural solutions. - September 24, 2025 - Natural Cure Labs
French Biotech 4Dcell Selected to Showcase Next-Gen Cardiac Drug Testing Platform at EIC Corporate Day
French Startup 4Dcell Wins Spot to Show Next-Gen Cardiac Drug Testing Platform at EIC - September 24, 2025 - 4Dcell
October is Havana Syndrome Awareness Month
October is Havana Syndrome Awareness Month. The purpose is to raise awareness about Havana Syndrome injuries caused by directed energy. - September 23, 2025 - Havana Syndrome, Inc.
Wecan Engineering Solutions Expands Product Range with Innovative 3D Tumbler Mixer
Wecan Engineering Solutions, an established manufacturer of chocolate, food, and pharmaceutical machinery, proudly introduces its 3D Tumbler Mixer – a high-precision solution for uniform powder and granule mixing. The mixer operates on a multi-directional movement principle, which ensures complete blending without dead zones. Unlike conventional mixers, the 3D Tumbler Mixer gently handles materials, protecting particle integrity while delivering consistent results. - September 20, 2025 - Wecan Engineering Solutions
YOLO Immune Awarded National Science Foundation SBIR Grant to Advance Novel Immunotherapy for the Treatment of Autoimmune Diseases
YOLO Immune, Inc., a venture-backed biotech company developing precision immunotherapies for the treatment of serious human diseases, today announced it has been awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Science Foundation (NSF). The NSF SBIR program is... - September 19, 2025 - YOLO Immune Inc
Precision Antibody to Attend the World Clinical Biomarkers & CDx Summit 2025 in Boston
Precision Antibody will attend the World CDx Summit 2025 in Boston, showcasing its expertise in biomarker antibody development and contributions to NCI’s CPTC program, reinforcing its role in advancing precision medicine. - September 19, 2025 - Precision Antibody
Creative Biolabs Finds a Way Out to Vitalize Functional Antibody Development
Creative Biolabs introduces how functional antibody development and supply are shaping biotech solutions and demonstrates solutions and scholarship opportunities. - September 19, 2025 - Creative Biolabs
Alera Bio Launches Lead Rare Disease Program with Exclusive Rights to MCT-8 Deficiency Therapy
Alera Bio secures exclusive license to advance AB-101, a first-in-class program for MCT-8 deficiency, with FDA Rare Pediatric Disease designation already in place. - September 18, 2025 - Alera Bio
Hospitality Veteran Brent O’Connor Joins PDS to Lead High-Impact Event Solutions Across Western Canada
Pacific Destination Services (PDS) has appointed Brent O’Connor as Sales Director, Corporate Hospitality & Events. With over 30 years of hospitality sales and marketing experience at brands like Sheraton, Westin, and Shangri-La, Brent will lead corporate sales strategies and deliver innovative event solutions across Western Canada. Recognized for driving revenue growth and building high-performing teams, his appointment comes as Vancouver prepares for major global events. - September 17, 2025 - Pacific Destination Services
BioSensics Awarded $5.2M NIH Grant to Advance Digital Biomarkers for PSP and DLB
BioSensics has received a 5-year/$5.2 million grant from the National Institutes of Health (NIH) to develop and validate novel digital biomarkers of disease activity in progressive supranuclear palsy (PSP) and dementia with Lewy bodies (DLB). This 5-year project will leverage BioSensics’ expertise in wearable sensors and digital health technologies and involve close collaboration with leading CurePSP Centers of Care and patient advocacy groups. - September 17, 2025 - BioSensics LLC
Dr. David Pincus of Pincus Plastic Surgery Named #1 Plastic Surgeon in New York and Florida by Hippo Medical
Board-Certified Plastic Surgeon Dr. David Pincus, founder of Pincus Plastic Surgery, has been honored with the America’s Top Plastic Surgeon Award by Hippo Medical, recognizing him as the #1 plastic surgeon in both New York and Florida for his excellence in patient safety, surgical artistry, and natural aesthetic results. - September 17, 2025 - Pincus Plastic Surgery
Microtrace Advances Product Authentication: Protect Revenue, Strengthen Brand Trust, and Enhance Operational Efficiency
Proprietary solutions secure device-consumable ecosystems, protect revenue streams, and deliver measurable business impact for global manufacturers. - September 16, 2025 - Microtrace LLC
Longevity World Cup Launches: A Global Sport Where Age is the Advantage
The Longevity World Cup, launching September 16, 2025, is the first global competition where athletes win by reversing their biological age. Rankings are based on verified tests using the PhenoAge clock, with categories by gender and generation. Prize money, funded in Bitcoin, goes to the top athletes. - September 16, 2025 - Longevity World Cup
Wecan Engineering Solutions Expands Global Reach with Innovative Chocolate, Food and Pharma Machinery
Founded in Gujarat, India, Wecan Engineering Solutions is a leading manufacturer and exporter of chocolate, food, and pharmaceutical machinery. With over seven years of expertise, the company has built a reputation for innovation, quality, and customer trust. Its vision is to deliver advanced engineering solutions that support the growth of food and pharmaceutical industries worldwide. - September 12, 2025 - Wecan Engineering Solutions
Lyfe RX Launches New Brand Identity, Bringing Science-Backed Wellness Solutions to Consumers Nationwide
Lyfe RX, formerly Live Well RX, announces its official rebrand and launch, introducing a fresh identity and expanded wellness offerings. With personalized weight management, peptide therapies, doctor-curated supplements, and high-protein meal prep, Lyfe RX delivers comprehensive, science-backed solutions to help customers achieve their health, longevity, and wellness goals. - September 10, 2025 - The Lyfe RX
National Brain Tumor Society Appoints Renowned Pediatric Oncologist as Chief Scientific Officer
National Brain Tumor Society names leading pediatric cancer expert, Dr. Susan Blaney, as new Chief Scientific Officer. - September 08, 2025 - National Brain Tumor Society